Traction retinal detachment. XLIX Edward Jackson Memorial Lecture

scientific article published on January 1993

Traction retinal detachment. XLIX Edward Jackson Memorial Lecture is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/S0002-9394(14)73518-4
P698PubMed publication ID8420359

P2093author name stringS J Ryan
P2860cites workAngiogenic factorsQ29620582
Retinal pigment epithelial cells produce PDGF-like proteins and secrete them into their mediaQ30460352
Combined posterior contusion and penetrating injury in the pig eye. II. Histological featuresQ33642309
Combined posterior contusion and penetrating injury in the pig eye. III. A controlled treatment trial of vitrectomyQ33642544
Experimental posterior penetrating eye injury in the rabbit. I. Method of production and natural historyQ33651343
Experimental posterior penetrating eye injury in the rabbit. II. Histology of wound, vitreous, and retinaQ33651348
Experimental posterior penetrating eye injury in the rhesus monkey: vitreous-lens admixtureQ33652201
An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytesQ33862469
Reoperation following diabetic vitrectomyQ35995242
Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degenerationQ36015882
Demonstration of vasoproliferative activity from mammalian retinaQ36201178
Intraoperative argon endophotocoagulation for recurrent vitreous hemorrhage after vitrectomy for diabetic retinopathy.Q36482916
Prognostic value of vitreous findings in diabetic retinopathyQ36654103
Growth factors in the eye.Q37806103
Proliferative vitreoretinopathy--is it anything more than wound healing at the wrong place?Q37922620
Diabetic dense premacular hemorrhage. A possible indication for prompt vitrectomyQ38396062
Pars plana vitrectomy techniques for relief of epiretinal traction by membrane segmentationQ39572290
Pathogenesis of proliferative neovascular retinopathies and the role of vitrectomy. A hypothesisQ39596809
Method of Production and Natural History of Experimental Posterior Penetrating eye Injury in the Rhesus MonkeyQ39681074
Timing of vitrectomy for active proliferative diabetic retinopathyQ41468300
Ultrastructure of traction retinal detachment in rhesus monkey eyes after a posterior penetrating ocular injury.Q41648196
Long-term results of vitrectomy and perfluorocarbon gas for the treatment of severe proliferative vitreoretinopathyQ43551067
Results and prognostic factors in vitrectomy for diabetic traction-rhegmatogenous retinal detachmentQ44179375
Rupture of the GlobeQ44326858
Silicone oil for progressive anterior ocular neovascularization after failed diabetic vitrectomyQ44337400
Macrophage modulation of retinal pigment epithelial cell migration and proliferationQ46080681
Classification of proliferative vitreoretinopathy used in the silicone study. The Silicone Study GroupQ46206390
Methods, statistical features, and baseline results of a standardized, multicentered ophthalmologic surgical trial: The silicone studyQ46209197
The Use of Liquid Silicone in Retinal Detachment SurgeryQ54509339
Immunohistologic Study of Epiretinal Membranes in Proliferative VitreoretinopathyQ57693445
Cytokines in proliferative vitreoretinopathyQ63407755
Pars Plana Vitrectomy in Ocular TraumaQ66936958
Guidelines in the management of penetrating ocular trauma with emphasis on the role and timing of pars plana vitrectomyQ67007803
A new concept for vitreous surgery. I. InstrumentationQ67268527
Vitrectomy for Complications of Diabetic RetinopathyQ67285234
Basic Fibroblast Growth Factor Levels in the Vitreous of Patients With Proliferative Diabetic RetinopathyQ67660782
Perfluoro-octane in the Treatment of Giant Retinal Tears with Proliferative VitreoretinopathyQ67873038
An updated classification of retinal detachment with proliferative vitreoretinopathyQ67938098
Vitrectomy with silicone oil or sulfur hexafluoride gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone Study Report 1Q68140147
Retinal pigment epithelial cells produce fibronectinQ68229136
Mechanisms involved in retinal pigment epithelial cell chemotaxisQ68954264
Pars plana vitrectomy for severe penetrating injury with posterior segment involvementQ68980322
Results and prognostic factors in vitrectomy for diabetic traction retinal detachment of the maculaQ68990347
Changing indications and techniques for vitrectomy in management of complications of diabetic retinopathyQ69006169
Proliferative vitreoretinopathy. The mechanism of development of vitreoretinal tractionQ69035039
Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Results of a randomized trial--Diabetic Retinopathy Vitrectomy Study Report 3. The Diabetic Retinopathy Vitrectomy Study Research GroupQ69054847
Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Clinical application of results of a randomized trial--Diabetic Retinopathy Vitrectomy Study Report 4. The Diabetic Retinopathy Vitrectomy Study Research GrouQ69054851
Long-term diabetic vitrectomy results. Report of 10 year follow-upQ69383919
Vitrectomy for progressive macular traction associated with proliferative diabetic retinopathyQ69463739
Proliferative vitreoretinopathy membranes. An immunohistochemical studyQ69513422
Cytoskeleton, adhesion, and extracellular matrix of fetal human retinal pigmented epithelial cells in cultureQ69592243
Results of vitrectomy for diabetic traction retinal detachments using the en bloc excision techniqueQ69643100
Results and prognostic factors in vitrectomy for diabetic vitreous hemorrhageQ69743322
Cryotherapy enhances intravitreal dispersion of viable retinal pigment epithelial cellsQ70069106
Platelet-derived growth factor is chemotactic for human retinal pigment epithelial cellsQ70083229
Proteins of the extracellular matrix in vitreoretinal membranesQ70214667
Surgical results in ocular trauma involving the posterior segmentQ70327906
Early vitrectomy in the management of the severely traumatized eyeQ70362684
A comparison of different cellular inocula in an experimental model of massive periretinal proliferationQ70362693
Effect of fibrin on morphologic characteristics of retinal pigment epithelial cellsQ70379814
Effect of vitreous on morphologic characteristics of retinal pigment epithelial cells. A new approach to the study of proliferative vitreoretinopathyQ70580542
Timing of vitrectomy after penetrating ocular injuriesQ70656221
Serum contains chemoattractants for human retinal pigment epithelial cellsQ70701795
Proliferative vitreoretinopathy: the rabbit cell injection model for screening of antiproliferative drugsQ70785893
Closed Vitrectomy in the Management of Diabetic Traction Retinal DetachmentQ70805818
Mechanisms in Traction Retinal DetachmentQ70871536
Pars Plana Vitrectomy for Diabetic Traction Retinal DetachmentQ70885402
Vitrectomy for Proliferative Diabetic Retinopathy Associated with Vitreous HemorrhageQ70885405
Control of experimental massive periretinal proliferation by daunomycin: dose-response relationQ71067804
Penetrating ocular injuries. Types of injuries and visual resultsQ71174758
Pars plana vitrectomy for complicated retinal detachmentsQ71174760
Posterior vitreous detachment in diabetic subjectsQ71221068
Factors influencing final visual results in severely injured eyesQ71380227
The lens influence on diabetic vitrectomy results. Report of a prospective randomized studyQ71429180
The natural history of diabetic extramacular traction retinal detachmentQ71466520
Vitrectomy in penetrating eye injury. Results of a controlled trial of vitrectomy in an experimental posterior penetrating eye injury in the rhesus monkeyQ71504158
The classification of retinal detachment with proliferative vitreoretinopathyQ71748348
Vitreous contraction in proliferative diabetic retinopathyQ72602729
The Effect of Lensectomy on the Incidence of Iris Neovascularization and Neovascular Glaucoma After Vitrectomy for Diabetic RetinopathyQ72685861
Vitrectomy for Diabetic Traction Retinal Detachment Involving the MaculaQ72685866
Vitrectomy for diabetic rhegmatogenous retinal detachmentQ72685869
Antiproliferative drugs in the treatment of experimental proliferative vitreoretinopathyQ72731604
Biomicroscopic study of vitreous cavity in diabetic retinopathyQ72760854
Two-year course of visual acuity in severe proliferative diabetic retinopathy with conventional management. Diabetic Retinopathy Vitrectomy Study (DRVS) report #1Q93559753
The pathophysiology of proliferative vitreoretinopathy in its managementQ93588666
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)1-20
P577publication date1993-01-01
P1433published inAmerican Journal of OphthalmologyQ4744258
P1476titleTraction retinal detachment. XLIX Edward Jackson Memorial Lecture
P478volume115

Reverse relations

cites work (P2860)
Q35679523A novel strategy to develop therapeutic approaches to prevent proliferative vitreoretinopathy
Q35582614Aqueous and alcoholic extracts of Triphala and their active compounds chebulagic acid and chebulinic acid prevented epithelial to mesenchymal transition in retinal pigment epithelial cells, by inhibiting SMAD-3 phosphorylation
Q44123219Basic fibroblast growth factor, glutamine synthetase, and interleukin-6 in vitreous fluid from eyes with retinal detachment complicated by proliferative vitreoretinopathy
Q49500666Cigarette smoke-induced EGFR activation promotes epithelial mesenchymal migration of human retinal pigment epithelial cells through regulation of the FAK-mediated Syk/Src pathway
Q33788729Controversies in the management of open-globe injuries involving the posterior segment
Q36716589Direct cyclopexy for traumatic cyclodialysis with persisting hypotony. Report in 29 consecutive patients
Q41257017Effect of Methotrexate on an In Vitro Patient-Derived Model of Proliferative Vitreoretinopathy
Q44405556Elevated proto-oncogene and collagen mRNA expression in PVR retinas
Q34427717Enhanced PKCδ and ERK signaling mediate cell migration of retinal pigment epithelial cells synergistically induced by HGF and EGF.
Q42688238Epiretinal membrane and cystoid macular edema as predictive factors of recurrent proliferative vitreoretinopathy
Q63407604Evidence of chronic inflammation in retina excised after relaxing retinotomy for anterior proliferative vitreoretinopathy
Q54597157Evidence of cross-link formation of vitreous collagen during experimental ocular inflammation.
Q35221367Expression of PDGFRα is a determinant of the PVR potential of ARPE19 cells
Q39898210Growth factors outside of the platelet-derived growth factor (PDGF) family employ reactive oxygen species/Src family kinases to activate PDGF receptor alpha and thereby promote proliferation and survival of cells
Q33557530Growth factors outside the PDGF family drive experimental PVR.
Q47401527Histopathological and ophthalmoscopic evaluation of apocynin on experimental proliferative vitreoretinopathy in rabbit eyes.
Q53066761In vitro vitamin K3 effect on conjunctival fibroblast migration and proliferation.
Q36008844Inhibition of DNA Methylation and Methyl-CpG-Binding Protein 2 Suppresses RPE Transdifferentiation: Relevance to Proliferative Vitreoretinopathy
Q41526638N-acetylcysteine suppresses retinal detachment in an experimental model of proliferative vitreoretinopathy
Q37315556Onset and recurrence of proliferative vitreoretinopathy in various vitreoretinal disease
Q41012721Orbital sonography in children
Q43116460PDGF receptors are activated in human epiretinal membranes
Q36164555Plasmin is the major protease responsible for processing PDGF-C in the vitreous of patients with proliferative vitreoretinopathy
Q44047478Posterior vitreous findings in cases of spontaneous retinal reattachment
Q77689407Primary vitrectomy for rhegmatogenous retinal detachment associated with choroidal detachment
Q77144020Proliferative vitreoretinopathy: an overview
Q34572836Proliferative vitreoretinopathy: risk factors and pathobiology
Q74151965Retinal detachment after posterior segment intraocular foreign body injuries
Q74429379Risk factors for proliferative vitreoretinopathy
Q46917842Risk factors for recurrent retinal detachment
Q43653223Shaken not stirred
Q73251170Surgical management of traumatic retinal detachment with perfluorocarbon liquid. The Vitreon Study Group
Q103804621Topical delivery of a small molecule RUNX1 transcription factor inhibitor for the treatment of proliferative vitreoretinopathy
Q35943908Vascular endothelial growth factor A competitively inhibits platelet-derived growth factor (PDGF)-dependent activation of PDGF receptor and subsequent signaling events and cellular responses
Q28250638Vascular endothelial growth factor and fibroblast growth factor 5 are colocalized in vascular and avascular epiretinal membranes
Q43093684Vitreous levels of intercellular adhesion molecule 1 (ICAM-1) as a risk indicator of proliferative vitreoretinopathy